(Sharecast News) – Barclays initiated coverage of Morgan Advanced Materials on Friday with an ‘overweight’ rating and 365p price target.
“We think improving end-market exposure will drive higher through-cycle growth for MGAM, with the group EBITA margin expanding to mid-teens and a new peak,” it said.
The bank noted that focused M&A is on the agenda, but said it also sees scope for a supportive capital return, while longer term further portfolio rationalisation could drive multiple expansion.
(Sharecast News) - Jefferies has upgraded its rating on GlaxoSmithKline to 'buy' and cut AstraZeneca to 'hold' as part of its review of the European pharma sector. "We are positive on sector fundamentals but see 2024 headwinds: a relative scarcity of big catalysts, US...
(Sharecast News) - RBC Capital Markets cut its price target on Rentokil Initial on Wednesday to 575p from 610p as it downgraded forecasts for forex and a greater back-end loading of TMX synergies, but said it believes the long-term story remains intact. The bank said...
(Sharecast News) - Citi has lifted its target price for data analytics and consumer credit reporting group Experian after a near-30% jump in the stock in the past two months, but has maintained a 'neutral' rating on the stock. Citi said back in August that while US...
Subscribe to our mailing list to receive regular updates!
